HealthNews

FDA rejects Rexulti-Zoloft combo for PTSD

September 23, 2025
Less than a minute

The FDA re­ject­ed Ot­su­ka and Lund­beck’s Rex­ul­ti and Zoloft com­bi­na­tion treat­ment for PTSD, months af­ter rais­ing con­cerns about the reg­i­men’s ef­fi­ca­cy at an ad­vi­so­ry com­mit­tee …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.


Source link

Related posts:

  1. FDA Panel Rejects Combo Drug for PTSD
  2. FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD
  3. New analysis reveals hidden economic burden of PTSD in the UK
  4. People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?
See also  Multiple people stabbed on train in England, 2 arrested
Tags
September 23, 2025
Less than a minute
Photo of Digit

Digit

Digit is a versatile content creator with expertise in Health, Technology, Movies, and News. With over 7 years of experience, he delivers well-researched, engaging, and insightful articles that inform and entertain readers. Passionate about keeping his audience updated with accurate and relevant information, Digit combines factual reporting with actionable insights. Follow his latest updates and analyses on DigitPatrox.
Back to top button
close